Kiniksa Pharmaceuticals Ltd

Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT

Kiniksa Pharmaceuticals Ltd (KNSA) SEC filings

Kiniksa Pharmaceuticals Ltd (KNSA) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B. The KNSA filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Kiniksa Pharmaceuticals Ltd said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

Earnings & events

All events

Event insights for KNSA — what management said, what changed, and why it matters.

Recent filings

These filings as JSON? API free 100/day

KNSA SEC filings FAQ

What is the latest KNSA SEC filing?

The latest cached Kiniksa Pharmaceuticals Ltd (KNSA) filing on this page is 8-K · Jul 28, 2026. Filings: https://lician.com/sec/knsa

What is the latest KNSA filing accession number?

The latest cached Kiniksa Pharmaceuticals Ltd (KNSA) accession number on this page is 0001730430-26-000031. Filing: https://lician.com/sec/knsa/0001730430-26-000031

Which item codes are on the latest KNSA filing?

Cached item codes on the latest Kiniksa Pharmaceuticals Ltd (KNSA) 8-K are 2.02, 9.01.

How many KNSA SEC filings are listed on this page?

This page lists 3 cached Kiniksa Pharmaceuticals Ltd (KNSA) SEC filings. Filings: https://lician.com/sec/knsa

What events are listed on the KNSA SEC page?

Cached event headlines on this Kiniksa Pharmaceuticals Ltd (KNSA) SEC page: "KNSA earnings". Events: https://lician.com/sec/knsa

What are KNSA's latest revenue and net income?

Latest cached Kiniksa Pharmaceuticals Ltd (KNSA) revenue for Dec 31, 2025 was $677.6M. Net income was $59.0M. Statements: https://lician.com/financials/knsa